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Urinary Metallothionein as an Indicator of
Cadmium Body Burden and of
Cadmium-Induced Nephrotoxicity
by Zahir A. Shaikh* and Chiharu Tohyamat
There is a need to identify specific biological indicator(s) ofcadmium exposure so that
the renal damage can be prevented. Towards this end, we have examined the usefulness
of urinary metallothionein as an indicator ofcadmium body burden. It is found that, in
both animals and humans, urinary metallothionein level is related to the hepatic and
renal cadmium burdens. Significant correlations are also found between the urinary
metallothionein andurinarycadmium and02-microglobulin. Furthermore, itis noted that
cadmium-exposed individuals with renal dysfunction excrete significantly more metal-
lothionein than those with normal renal function. Thus it appears that there is merit to
include metallothionein among the clinical parameters monitored in cadmium-exposed
individuals. More tests are needed to define a critical concentration ofmetaliothionein in
urine which is related to the onset ofrenal dysfunction.
Thebiological function ofmetallothionein (MT)
remains unclear. However, it appears that in
chronic cadmium (Cd) exposure the protein is
induced in liver, kidney and other tissues and is
responsible for sequestration of the metal. The
metal-protein complex is synthesized on free po-
lysomes and, therefore, remains largely intracel-
lular. Nevertheless, small amounts of Cd bound
to MT-like protein have been detected in plasma
ofanimals injected with Cd (1,2). Studies by Toh-
yama and Shaikh (3) and by others (4) have
confirmed the existence of MT in plasma by im-
munological methods. The circulating Cd-MT is
efficiently filtered andtaken up by the kidneys. If
the concentration ofCd-MT is increased by exper-
imental injection, the proximal renal tubular epi-
thelium is damaged, resembling very much the
pathology seen after chronic Cd administration
(5-7). The filtered Cd-MT is, however, not com-
pletely reabsorbed and low concentrations ofthe
protein are detectable in urine (2,8,9). With the
progression ofrenal damage, the excretion ofCd-
MT, like other low molecular weight plasma pro-
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teins (i.e., 32-microglobulin, retinol-binding pro-
tein, lysozyme, etc.), increases inurine (2). Recent
studies by our group (10-12) have examined the
practical importance of quantitating extracellu-
lar MT for estimation ofCd body burden and also
for determining the Cd-induced renal dysfunc-
tion. This paper summarizes some of the main
points.
Metallothionein and Cadmium
Body Burden
Studies in Animals
Using a radioimmunassay developed in our la-
boratory, MT was quantitated in the plasma and
urine ofrats injectedwith Cd. As shown in Figure
1, the concentration of the protein increases in
both plasma and urine with the duration oftreat-
ment, up to about 8-10 weeks. The renal dysfunc-
tion which is evident at this time and presents
itselfas proteinuria and glucosuria (2) causes the
plasma MT concentration to plateau, while ele-
vating the MT concentration in urine. Further
analysis showed that, in the absence of renal
dysfunction, the urinary MT is related to both
hepatic and renal Cd burdens (11), thus strength-
ening the argument that it is an indicator ofbody
burden.SHAIKH AND TOHYAMA
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DURATION OF CADMIUM EXPOSURE (WEEKS)
FIGURE 1. Plasma and urinary MTlevels ofrats given5[tmole
CdCl2/kg daily, 5 days/week, via subcutaneous injection.
Mean ± SE for 3-6 rats is plotted.
Studies in Humans
The association between Cd exposure and uri-
nary MT level was further explored in workers at
a Cd smelter (11). In general, the workers with
longer employment history had higher MT levels
in their urine than the workers with shorter em-
ployment at the smelter (11,13). When the urinary
MT values were compared with the hepatic or
renal values, determined by in vivo neutron acti-
vation analysis (14), there was a significant cor-
relation between the MT and tissue Cd (Fig. 2).
This observation confirmed the studies in animals
where a similar correlation was noted (11). There
are two other interesting points regarding the
data shown in Figure 2. Whereas the hepatic Cd
concentration of all workers (with and without
renal dysfunction) was related to the urinary MT,
the renal Cd was related to MT only in case of
subjects with normal renal function. This may be
indirect evidence that the main source of urinary
MT is probably the liver.
The assocation between the urinary MT and Cd
exposure was further evaluated in a study in envi-
ronmentally exposed Japanese women (12). There
have been reports stating that urinary Cd is re-
lated to the body burden under chronic exposure
situations (15). We compared the Cd and MT con-
centrations in urine to evaluate whether there
existed any relationship between the two. The
data depicted in Figure 3 show that there is in-
deed a significant relationship between Cd and
MT levels in urine.
It may be argued that the determination of MT
in urine, for the purpose of estimating the body
burden, is no better a parameter than Cd in urine,
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FIGURE 2. Relationship ofhepatic and renal Cd with urinary
MT in Cd-smelter workers. The open circles denote two
individuals with renal dysfunction; these were not taken
into account when plotting the regression line in the bot-
tomfigure. The correlation coefficientfordata shown inthe
top graph is 0.75 (p < 0.01) and that in the bottom graph is
0.85 (p < 0.01).
except that the latter is prone to contamination
errors. Further work is needed to evaluate the
potential importance of urinary MT as a superior
marker of Cd body burden, especially under occu-
pational exposure situations, where blood and uri-
nary Cd may fluctuate on a daily basis, depending
on the extent of exposure. An important point to
remember, though, is that urinary Cd-MT is an
indicator of tissue Cd burden whereas the non-
MT-bound Cd in urine, like blood Cd, may be more
related to recent exposure.
Metallothionein and Renal
Function
Studies in Animals
The filtered MT is efficiently reabsorbed by the
kidney under normal circumstances. Any im-
pairment in the tubular function, however, results
in marked excretion of the protein in urine. As
shown in Figure 1 and previous studies (2,11),
upon development of renal dysfunction, the Cd-
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FIGURE 3. Relationship ofurinaryCd and MT in subjects from
Kanazawa City, Japan, a nonpolluted area (@) and from
Jinzu River basin, a Cd-polluted area (A). The correlation
coefficient is 0.80 (p < 0.001).
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FIGURE 4. Relationship of urinary 02-microglobulin and MT
in subjects from (e) Kanazawa City and (A) Jinzu River
basin. The correlation coefficient is 0.78 (p < 0.001).
treated rats do excrete high concentrations of MT
in urine. Thus, the excretion of MT in urine ap-
pears to be dependent on renal function.
Studies in Humans
,32-microblogulin, a low molecular weight pro-
tein, is a non-specific but widely used indicator of
renal tubular function. Since the molecular weight
of MT is even smaller than P2-microglobulin, we
examined the correlation between MT and 02-
microglobulin in urine to see ifthe excretion ofthe
two proteins follows the same pattern (12). This
indeed was the case, i.e., the concentration of MT
in urine increased with the increase in 12-
microglobulin in urine (Fig. 4). However, whereas
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FIGURE 5. MT levels in urine of67 Japanese women consist-
ing of Itai-Itai disease patients, patients suspected of the
disease, subjects from a Cd-polluted area (Jinzu River
basin), and from a nonpolluted area (Kanazawa City). The
subjects were divided into two groups: those with normal
renal function (first column) and those with abnormal
renal function (second column). The parameters ofnormal
renal function were: protein (- 250 mg/g creatinine), glu-
cose (- 200 pg/L), and 02-microglobulin (S 200 jg/g creati-
nine). The number in each column indicates the number of
subjects in that category. Asterisks (*) denote significant
differences atp<0.001.
the 032-microglobulinuria levels varied four orders
of magnitude, those of MT varied only about one
and a half orders of magnitude. Thus, one may
conclude that ,32-microglobulin in urine is a more
sensitive indicator of renal function than MT.
Nevertheless, MT is more specific for an indicator
of Cd-induced renal dysfunction than 12-
microglobulin.
Additional data from Itai-Itai disease patients
and other Cd-exposed Japanese women revealed
that there was significantly greater excretion of
MT associated with proteinuria, glucosuria and
,32-microglobulin (Fig. 5) than with normal urine
chemistry.
Conclusions
From the data presented in this paper, it ap-
pears that the urinary MT level is related to the
tissue Cd under normal renal function and that
the elevated MT levels are an indication of im-
paired renal function due to chronic Cd exposure.
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